At the heart of Ketel One Vodka lies one family’s unwavering passion for crafting the world’s finest spirits. Inspired by over 325 years of distilling expertise, the Nolet family brings old-world pot still craft and modern distilling techniques together in one flawless process. From Joannes to Jacobus to Carolus Sr., creator of Ketel One Vodka, to Carolus Jr. and Bob Nolet today, each of the 11 generations of Nolet family distillers is tasked with upholding a legacy of distilling excellence. Some may consider the Nolets a little obsessive, but those individuals just don’t understand. Everything must be done with meticulous attention to detail, because the family name is riding on every bottle of Ketel One Vodka.
“We take our work very seriously, not ourselves,” said Carl Nolet Jr., 11th Generation Nolet Family Distillery. “The stories we tell are all true and based on family events, beliefs and the pressure of upholding 11 generations of legacy for generations to come.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7975151-ketel-one-vodka
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
The Partnership for Drug-Free Kids, a national nonprofit dedicated to reducing substance abuse among adolescents, today launched a new multimedia campaign for teens that illustrates some of the pressures they face, including peer pressure to drink and use drugs, issues with body image and bullying, among others. The “Who Controls You” campaign breaks this month and was created pro-bono by advertising agency, Hill Holliday and award-winning, social media influencer, Maris Jones, as part of the Partnership’s Above the Influence (ATI) teen program.
“We are incredibly proud of this work. We struck gold when Hill Holliday collaborated with Adolescent Media and Maris Jones to bring this campaign to life,” said Chief Marketing Officer for the Partnership for Drug-Free Kids, Kristi Rowe. “Partnering with a young, talented social media influencer like Maris lent such a unique and authentic voice to this effort. Combining the extraordinary insight and passion of the Hill Holliday team with Maris’ distinct artistry brought an unexpected style to the campaign that makes this creative truly break through.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7103751-drug-free-partnership-who-controls-you/
Wacom® today announces new Bamboo stylus products at IFA Berlin 2015. Leading the charge is the fine tip smart stylus for iPad: Bamboo®Fineline 2, a high-precision digital pen allowing creative thinkers to capture and shape their ideas.
“Our customer’s feedback drove the updates for our existing pen products,” Mike Gay, senior vice president of the consumer business unit at Wacom stated. “Wacom refined its pressure sensitive pen for the iPad to recreate the feel of writing with pen on paper. Bamboo Fineline 2 is the perfect complement to our Bamboo Paper app, allowing users to easily save, edit and share their work. Combined with the Wacom Cloud, this complete solution enables our customers to make their ideas a reality using their iPad.”
Bamboo Fineline 2’s improved industrial design provides a better writing experience and improved comfort. The battery for the Bamboo Fineline 2 lasts approximately 20 hours and is easily recharged via USB cable.
To view the multimedia release go to:
http://www.multivu.com/players/English/7613151-wacom-making-ideas-bamboo-fineline/
Booking.com, the world’s number one accommodation site, today announces the launch of the Booking Now app for the Apple Watch. Booking Now, which draws from Booking.com’s vast selection of over 625,000 properties in more than 75,000 unique destinations, is the first and only travel app to enable users to book a stay directly from their Watch, and in just one touch. Through the use of Apple’s new pressure sensitive ‘force touch’ technology, spontaneous travelers are now able to choose and book the nearest relevant hotel in one simple gesture.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7504251-booking-travel-app-for-apple-watch/
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
Centennial College's Police Foundations program is a two-year program that consists of intense training equivalent to that of a paramilitary environment, which helps students to develop discipline and deportment. Courses are based on real-life experiences and case studies that incorporate a fundamental perspective on life. The program successfully prepares graduates for careers in the various police and military forces or in the field of security and related occupations and they have the ability to withstand pressure, communicate effectively, act as problem-solvers and help people in the community.
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Junior Achievement USA® (JA) today announced the launch of its JA Heroes PSA campaign. The goal of this campaign is to connect volunteer mentors with young people to give kids the power to see their future, unleash their potential and let their dreams take flight.
Positive role models in the lives of young people are shown to help inspire them to overcome difficult circumstances. Yet today, millions of kids live in situations where they do not have access to mentors who can give them the guidance or insight they need to rise above negative peer pressure, economic uncertainty or simply a lack of direction.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7553451-ja-heroes-psa-campaign/
Cigna (NYSE: CI) today unveiled its new TV Doctors of America campaign to encourage people to improve their health by going for their annual check-up, knowing their biometric numbers for blood pressure, cholesterol, blood sugar and body mass index (BMI), and taking control of their health. Supporting Cigna’s effort are actors Patrick Dempsey, Donald Faison, Neil Patrick Harris and Kate Walsh. All four actors starred as doctors on TV and are striking doctor poses, donning scrubs and using their celebrity influence to shine a spotlight on preventive care and the importance of going to a real doctor for an annual check-up that can help save lives.
To view the multimedia release go to:
https://www.multivu.com/players/English/8163851-cigna-americas-tv-doctors-go-know-take-control/
Today, VSP Vision Care, the largest not-for-profit vision benefits provider in the United States, and market research agency YouGov released new findings showing that half of people in the U.S. are neglecting their eyes despite 84 percent of people rating vision as their most important sense. This disconnect occurs because people don’t understand the importance of annual eye exams and its connection to overall health.
In fact, only 1 percent of people know that signs of serious conditions like thyroid disease, high blood pressure, autoimmune disorders and certain types of cancer can be detected through annual eye exams. This is concerning because even if you have naturally good vision and don’t need prescription glasses, you still need an annual eye exam to protect your overall health.
To view the multimedia release go to:
https://www.multivu.com/players/English/8363551-vsp-vision-care/
Apollo 15- Astronaut Says He Peed On The Rover- and They Say it Hurts Having To Lie -On The Real Moon Naked Skin Cannot Be Exposed To The Outside Pressure.
This video as you hear & see it, is located for download at NASA site:
http://history.nasa.gov/alsj/a15/video15.html
Apollo 15 Video Library
Loading the Rover
Journal Text: 120:48:05
ALL NASA FOOTAGE USED IN THIS VIDEO IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
